L57- Pharmadynamics Flashcards
What is efficacy?
describes the ability of the drug, after binding to the receptor, to activate transduction mechanisms that lead to a response”
what is intrinsic efficacy?
describes the ability of the drug, after binding to the receptor, to activate transduction mechanisms that lead to a response in a tissue
why are tissues different from each other?
◦ different number of receptors present
◦ different nature of coupling of receptors to response
◦ different drugs (different interaction with different parts of tissue?)
what is an agonist?
a drug has affinity, high efficacy and rapid rate of association and dissociation with its receptor
what is a partial agonist?
- a drug has affinity, weak efficacy and moderate association and dissociation. It produces an effect < the full agonist when it has saturated the receptors. It acts as antagonist in the presence of full agonist.
- it can look like a full agonist
what is a antagonist?
- drug that prevents the action of an agonist.
- Antagonist has affinity for a receptor, but does not produce a conformational change in the receptor protein
- little of no efficacy
- has affinity
what is an inverse agonist?
it turns of the small activation a receptor may have in the absence of an agonist
what is a competitive antagonist?
-The antagonist binds reversibly with the receptor and could be displaced by
excessive dose of agonist
-The competitive antagonist decreases the potency of the agonist but does not alter its maximal effect
describe the dose-response curve?
- displaced to the right in a parallel manner in the presence of the antagonist
- the higher the concentration of antagonist the more the curve is to the right
- the maximum receptor activation doesn’t change
- x=ligand conc log y=change in receptor activation
what is pA2 value?
represents the negative logarithm of the molar dose of antagonist to produce a dose ratio of 2
Dose Ratio (DR) =
EC50 in presence of antagonist/EC50 in absence of antagonist
how does a competitive antagonist work?
the antagonist covalently binds to the agonist binding site of the receptor
what happened to the ‘change in receptor activation’ as the conecntration of antagonists increase?
it decreases
what happened to the ‘change in receptor activation’ as the concentration of antagonists increase?
it decreases
what type of antagonist does not displace the agonist?
- non-competitive antagonist
- The non-competitive antagonist decreases the potency and the maximal effect of the agonist